IHS Chemical Week

Regions :: Western Europe :: Belgium

Solvay Reports Third-Quarter Profits Down; Evaluates Options for Reinvestment of Pharma Proceeds

4:01 AM MDT | October 29, 2009 | Natasha Alperowicz

Solvay reported a 2% decrease in third quarter recurring earnings before interest and taxes (Rebit) at €285 million ($424 million) on 10% lower sales of €2.24 billion, citing difficult market conditions. Earnings before interest and tax (Ebit) fell 32% to €255 million. Of Solvay's three business segments, chemicals, plastics and pharmaceuticals, only the pharma unit showed an increase in sales and Rebit. Solvay is selling the pharma business. Chemicals' Rebit was down 21% at €56 million on 18% lower sales of €658...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa